04:27 PM EST, 01/02/2025 (MT Newswires) -- Lifecore Biomedical ( LFCR ) reported late Thursday its fiscal Q2 swung to a loss of $0.25 per diluted share from earnings of $0.39 per share a year earlier.

Three analysts polled by FactSet expected a loss of $0.29.

Revenue for the three months ended Nov. 24 was $32.6 million, up from $30.2 million a year ago.

Three analysts polled by FactSet expected $29.7 million.